Personalised Breast Cancer Program

• Research type

  Research Study

• Full title

  Personalised Breast Cancer Program - Feasibility study

• IRAS ID

  202373

• Contact name

  Jean Abraham

• Contact email

  ja344@medschl.cam.ac.uk

• Sponsor organisation

  Cambridge University Hospitals NHS Foundation Trust and University of Cambridge

• Duration of Study in the UK

  11 years, 7 months, 30 days

• Research summary

  This is a feasibility study to demonstrate that Whole Genome Sequencing (WGS) of breast cancer patients can be conducted and completed in a clinically acceptable time period of 12 weeks in the setting of an NHS oncology unit.
  The initial results of this feasibility study relating to the turn-around timeframes will be used to develop a full study where the outcome of the WGS will be taken into consideration when prescribing treatment to breast cancer patients.

• REC name

  East of England - Cambridge Central Research Ethics Committee

• REC reference

  16/EE/0100

• Date of REC Opinion

  17 Jun 2016

• REC opinion

  Further Information Favourable Opinion